•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Trulieve Cannabis Corp. said it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state-licensed medical marijuana operations under an expedited registration pathway tied to the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Following the reclassification of medical marijuana to Schedule III, the DEA created an expedited registration process for eligible state-licensed medical marijuana operators. Trulieve said that for operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified.
“DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve,” said Trulieve Chief Executive Officer Kim Rivers. “With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis.”
Trulieve is a vertically integrated cannabis company and multi-state operator in the U.S., with hubs in the Northeast, Southeast, and Southwest, anchored by cornerstone markets in Arizona, Florida, Ohio, and Pennsylvania. The company said it serves customers with branded products and experiences, supported by scaled operations in selected markets and expansion through its hub strategy.
Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
[email protected]
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
